To: kpf who wrote (155919 ) 4/13/2005 2:09:58 PM From: Biomaven Read Replies (1) | Respond to of 275872 kpf100, Companies sometimes break this out as stock-based compensation, and often mention that it is a non-cash charge. Going back and looking at AMD's 10-K, I'm not seeing much in the way of in-the-money option grants over the past three years at all (aside from some Restricted Stock, for which there is of course a charge):The Company granted a total of 25,999,480 stock-based awards during 2004 with exercise prices equal to the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $14.56 and $8.20. The Company granted a total of 80,265 stock-based awards during 2004 with exercise prices greater than the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $14.54 and $6.34. The Company granted 41,000 stock-based awards in 2004 at less than the closing price of its common stock on the grant date, excluding 43,000 shares of restricted stock granted in 2004 at less than closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $1.39 and $13.61. The Company granted a total of 5,566,484 stock-based awards during 2003 with exercise prices equal to the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $9.46 and $5.67. The Company granted a total of 8,745 stock-based awards during 2003 with exercise prices greater than the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $9.54 and $4.05. The Company did not grant stock-based awards during 2003 with exercise prices less than the closing price of its common stock on the grant date. The Company granted a total of 11,527,551 stock-based awards during 2002 with exercise prices equal to the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $9.86 and $5.48. The Company granted a total of 114,980 stock-based awards during 2002 with exercise prices greater than the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $12.73 and $5.89. The Company granted a total of 186,157 stock-based awards during 2002 with exercise prices less than the closing price of its common stock on the grant date. The weighted-average exercise price and weighted-average fair value of these awards were $0.08 and $13.70. Peter